uu.seUppsala universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Quantitative modeling of inter-lesion andinter-organ variability of tumor size
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Farmaceutiska fakulteten, Institutionen för farmaceutisk biovetenskap.
2019 (engelsk)Independent thesis Advanced level (degree of Master (Two Years)), 30 poäng / 45 hpOppgave
Abstract [en]

ABSTRACT

In metastatic cancer, the growth and drug-induced shrinkage of individual tumor lesions may behighly dependent on the microenvironment of the hosting organ, and individual lesions cancontribute differently to overall disease progression and survival. In the traditional analysis of tumorresponse to treatment, the overall measurement of patient tumor burden is used, i.e. the sum of thelongest diameters (SLD) of up to 10 lesions (RECIST criteria v 1.0). Information carried byindividual lesions and their impact on the disease outcome is hence ignored. This analysis aimed todevelop a population model to better understand and characterize the differences in tumor dynamicsbetween lesions and different metastatic sites. Using lesion measurement data from 183 subjectswith metastatic HER2-negative breast cancer receiving docetaxel, a kinetic/pharmacodynamic modelhas been developed. The framework model was able to describe metastatic breast cancer data on thelevel of lesion, organ, and patient. Besides, a logistic regression dropout model allowed to accountfor the loss of follow-up based on tumor size and identify influencing covariates. A new lesionappearance model was able to predict the development of new metastasis and find predictors.Finally, an overall survival model enabled exploring the relationship between tumor measurementand survival expectancy. This developed framework may provide a better understanding of therelationship between drug exposure and tumor response on the level of lesion, organ, and patient.Thus, it may help drive decisions in clinical studies and increase our knowledge about metastasis.

sted, utgiver, år, opplag, sider
2019. , s. 27
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-390897OAI: oai:DiVA.org:uu-390897DiVA, id: diva2:1343119
Veileder
Examiner
Tilgjengelig fra: 2019-08-15 Laget: 2019-08-15 Sist oppdatert: 2019-08-15bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Av organisasjonen

Søk utenfor DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric

urn-nbn
Totalt: 20 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf